NEWARK, Calif., Jan. 3, 2024 /PRNewswire/ -- CymaBay Therapeutics, Inc. (CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today ...
(RTTNews) - CymaBay Therapeutics Inc. (CBAY), on Wednesday, announced new published data from a post-hoc analysis of its phase III ENHANCE study of Seladelpar demonstrating a correlation between itch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback